Therefore Herceptin and anthracyclines should not be used currently in combination except in a well-controlled clinical trial setting with cardiac monitoring.
Dėl to Herceptin negalima skirti tuo pat metu su antraciklinais, išskyrus gerai kontroliuojamus klinikinius bandymus, kai atliekamas širdies funkcijų monitoringas.